CHENG Weihua, GUO Feihu, DENG Xuesong, QIN Xiangyu, FAN Hongqiang, HU Ji. Research progress of synthetic methods of [18F]F-DOPA[J]. Journal of China Pharmaceutical University, 2019, 50(3): 357-363. DOI: 10.11665/j.issn.1000-5048.20190313
Citation:
CHENG Weihua, GUO Feihu, DENG Xuesong, QIN Xiangyu, FAN Hongqiang, HU Ji. Research progress of synthetic methods of [18F]F-DOPA[J]. Journal of China Pharmaceutical University, 2019, 50(3): 357-363. DOI: 10.11665/j.issn.1000-5048.20190313
CHENG Weihua, GUO Feihu, DENG Xuesong, QIN Xiangyu, FAN Hongqiang, HU Ji. Research progress of synthetic methods of [18F]F-DOPA[J]. Journal of China Pharmaceutical University, 2019, 50(3): 357-363. DOI: 10.11665/j.issn.1000-5048.20190313
Citation:
CHENG Weihua, GUO Feihu, DENG Xuesong, QIN Xiangyu, FAN Hongqiang, HU Ji. Research progress of synthetic methods of [18F]F-DOPA[J]. Journal of China Pharmaceutical University, 2019, 50(3): 357-363. DOI: 10.11665/j.issn.1000-5048.20190313
Research progress of synthetic methods of [18F]F-DOPA
[18F]6-fluoro-3, 4-dihydroxy-L-phenylalanine([18F]F-DOPA)has been used as a radiotracer for Parkinson′s disease over 30 years. The previously reported electrophilic synthesis method has low radiochemical yield(RCY), low specific activity(SA)and other defects. Recent reported nucleophilic synthesis of [18F]F-DOPA could overcome the disadvantages. In this paper, the nucleophilic synthetic methods for [18F]F-DOPA are reviewed.